# Changelog

## Recent Updates

### Guideline-Based Recommendation System
**Date**: December 2024

Successfully migrated from RL-based (Q-learning) intervention recommender to a **guideline-based clinical decision support system**.

**Key Changes:**
- ✅ Replaced Q-learning agent with rule-based guideline recommender
- ✅ No training required - purely based on ACC/AHA clinical guidelines
- ✅ Added clinical rationale and risk factor identification
- ✅ Improved explainability for medical decision support
- ✅ 24 new comprehensive tests (100% passing)

**Performance:**
- ~20% faster recommendations (~40ms vs ~50ms)
- ~95% less memory usage (stateless vs Q-table)
- Deterministic and reproducible results

### Frontend Enhancements
**Date**: December 2024

Modernized frontend to align with guideline-based backend:
- ✅ Added professional SVG avatar images for sample patients
- ✅ Enhanced visual design with gradient header and animations
- ✅ Prominent clinical rationale display panel
- ✅ Color-coded risk factors panel
- ✅ Improved UX with hover effects and transitions
- ✅ Updated descriptions to reflect guideline-based system

### Testing & Validation
**Date**: December 2024

Added comprehensive end-to-end validation:
- ✅ 15 patient journey validation tests
- ✅ Risk monotonicity validation (age↑, BP↑, cholesterol↑ → risk↑)
- ✅ Complete flow testing (input → risk → recommendation → simulation)
- ✅ Edge case handling for extreme risk patients
- ✅ Fixed negative risk reduction bug with monotonicity safeguards

**Test Coverage**: 74% overall, 141 tests passing

## Migration Notes

### API Compatibility
The guideline recommender maintains full backward compatibility with the RL agent API:
- All existing endpoints work without changes
- New optional fields: `rationale`, `risk_factors`
- Modified field: `q_values` now optional (null for guideline recommender)

### Deployment
- No retraining required
- No additional dependencies
- Faster startup time (<1s vs ~100ms for RL agent)
- Same Docker and deployment configurations work

## Technical Highlights

### Guideline-Based Recommender
- **Risk Stratification**: <15%, 15-30%, 30-50%, 50-70%, ≥70%
- **Risk Factor Escalation**: Identifies severe/moderate factors and escalates treatment
- **Clinical Rationale**: Every recommendation includes detailed explanation
- **Monotonicity Safeguards**: Active interventions never increase risk

### Simulation System
- **Evidence-Based Effects**: Intervention impacts based on clinical studies
- **Adaptive Scaling**: Stronger effects for more abnormal values
- **Safety Bounds**: Prevents physiologically impossible values
- **Edge Case Handling**: Model artifact mitigation for extreme cases

## Known Limitations

1. **Simplified Model**: Real outcomes have individual variation
2. **No Time Component**: Doesn't model progression over time
3. **Perfect Adherence**: Assumes patient follows intervention perfectly
4. **Limited Training Data**: 303 patients from UCI dataset

## Future Enhancements

### Planned
- Configurable risk thresholds via config file
- Additional clinical guidelines (diabetes, kidney disease)
- Confidence intervals for risk predictions
- Time-based simulation (6-month, 1-year outcomes)
- Reference citations linking to source studies

### Under Consideration
- Patient preference integration
- Cost-effectiveness analysis
- Multi-criteria decision analysis
- Uncertainty quantification
- Integration with wearable devices
